These functions make it a key nutrient for maintaining energy, mental clarity, and overall wellness
Please note orders placed on a Friday after 5pm and over a weekend will be dispatched the following Monday
On December 20, 2024, Eli Lilly announced the FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity. AASM.org Among persons with moderate-to-severe obstructive sleep apnea and obesity, tirzepatide reduced the AHI, body weight, hypoxic burden, hsCRP concentration, and systolic blood pressure and improved sleep-related patient-reported outcomes. NIH study Can the makers of these new weight loss medications really claim to treat and cure Obstructive Sleep Apnea (OSA)
It functions well in the form of a skin-enhancing nutrient when used in combination with a proper diet
However, high doses ( 0.5 mg/kg/d) may activate the SREBP-1c pathway, increase liver fat synthesis, and lead to hypertriglyceridemia and fatty liver
At low concentrations (0.01 nM), MMP1 and MMP2 gene expression increases, facilitating removal of damaged extracellular matrix proteins